The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2023

Filed:

Jul. 11, 2019
Applicants:

Beijing Dcty Biotech Co., Ltd., Beijing, CN;

Shunchang Jiao, Beijing, CN;

Inventors:

Shunchang Jiao, Beijing, CN;

Rong Zhang, Beijing, CN;

Tianfu Zhang, Beijing, CN;

Zishan Zhou, Beijing, CN;

Jiasen Xie, Beijing, CN;

Ziming Wu, Beijing, CN;

Gang Peng, Beijing, CN;

Assignees:

Beijing DCTY Biotech Co., Ltd., Beijing, CN;

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/85 (2006.01); C12N 5/0783 (2010.01); C07K 14/725 (2006.01); C12N 7/00 (2006.01); C12N 15/11 (2006.01); C12N 15/86 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0636 (2013.01); C07K 14/7051 (2013.01); C12N 7/00 (2013.01); C12N 15/11 (2013.01); C12N 15/86 (2013.01); G01N 33/505 (2013.01); C12N 2310/20 (2017.05); C12N 2501/998 (2013.01); C12N 2502/11 (2013.01); C12N 2510/00 (2013.01); C12N 2740/15043 (2013.01);
Abstract

Some embodiments of the disclosure use human peripheral blood for ctDNA sequencing or tumor tissues for whole exome sequencing, screen out mutation sites to perform antigen epitope prediction, connect and synthesize an expression gene sequence of mutant peptides. Other embodiments of the disclosure construct a lentiviral vector, package the lentivirus, transfect an APC cell to complete transformation of a specific LV cell, co-culture in vitro with PBMC separated from the peripheral blood, screen out an effective polypeptide, and transform common T cells into RFF cells. Suppressive signaling molecules include one or more of PD-1, Tim-3, LAG3, CTLA-4, BTLA, VISTA, CD160, and 2B4 (CD244). Antigen presenting cells include one or more of PBMC, a dendritic cell, neutrophil, B lymphocyte, and macrophage.


Find Patent Forward Citations

Loading…